This study elucidates the carcinogenic mechanisms of ATP1A2 in bladder cancer and provides an experimental basis for the development of precise ATP1A2-targeted treatment strategies targeting ATP1A2. The gene discussed is ATP1A2; the disease is urinary bladder carcinoma.